| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OS Therapies Inc | President and CEO, Director | Common Stock | 2,473,000 | $3,808,420 | $1.54 | 22 Jan 2026 | Direct |
| OS Therapies Inc | President and CEO, Director | Stock options (right to buy) | 1,000,000 | 22 Jan 2026 | Direct | ||
| OS Therapies Inc | President and CEO, Director | Non-qualified stock options (right to buy) | 800,000 | 05 Dec 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OSTX | OS Therapies Inc | 22 Jan 2026 | 1 | $0 | 4 | President and CEO, Director | 13 Feb 2026, 16:41 |
| OSTX | OS Therapies Inc | 21 Oct 2025 | 1 | $0 | 4/A | President and CEO, Director | 13 Feb 2026, 16:20 |
| OSTX | OS Therapies Inc | 28 Feb 2025 | 1 | $0 | 4 | President and CEO, Director, 10%+ Owner | 28 Feb 2025, 18:03 |
| OSTX | OS Therapies Inc | 31 Dec 2024 | 1 | $0 | 5 | President and CEO, Director, 10%+ Owner | 14 Feb 2025, 16:25 |
| OSTX | OS Therapies Inc | 31 Jul 2024 | 0 | $0 | 3 | President and CEO, Director, 10%+ Owner | 01 Aug 2024, 09:16 |